.jpg "Heska Corp (NASDAQ: HSKA)")
Today, the EVP, Diag. Ops & Prod. Dev. of Heska Corp (NASDAQ: HSKA), Nancy Wisnewski, sold shares of HSKA for $260.3K.
Following Nancy Wisnewski’s last HSKA Sell transaction on August 31, 2017, the stock climbed by 3.0%. In addition to Nancy Wisnewski, 2 other HSKA executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Heska Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $32.77 million and quarterly net profit of $2.16 million. In comparison, last year the company earned revenue of $30.38 million and had a net profit of $4.61 million. HSKA’s market cap is $777.3M and the company has a P/E ratio of 108.01. Currently, Heska Corp has an average volume of 66.23K.
Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $109.33, reflecting a -2.2% downside.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the Core Companion Animal Health; and Other Vaccines, and Pharmaceuticals and Products segments.
